Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Biard

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Statistics in Medicine|June 6, 2024
Two-stage randomized clinical trials with a right-censored endpoint: Comparison of frequentist and Bayesian adaptive designsLuana Boumendil, Sylvie Chevret, Vincent Lévy, et al.
Statistics in Medicine|October 19, 2022
Surv-CRM-12: A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progressionAnaïs Andrillon, Sylvie Chevret, Shing M Lee, et al.
Journal of Biopharmaceutical Statistics|November 23, 2020
Dose-finding design and benchmark for a right censored endpointAnaïs Andrillon, Sylvie Chevret, Shing M Lee, et al.
Journal of Biopharmaceutical Statistics|September 15, 2020
A simulation study of approaches for handling disease progression in dose-finding clinical trialsLucie Biard, Bin Cheng, Gulam A Manji, et al.
Clinical Trials (London, England)|April 9, 2024
Dose optimization for cancer treatments with considerations for late-onset toxicitiesLucie Biard, Anaïs Andrillon, Rebecca B Silva, et al.
Plos One|November 21, 2012
Case-only designs in pharmacoepidemiology: a systematic reviewSandra Nordmann, Lucie Biard, Philippe Ravaud, et al.
The Lancet. Infectious Diseases|February 2, 2020
Infectious disease consultation for candidaemiaJerome Lambert, Maja von Cube, Lucie Biard, et al.
Biometrical Journal. Biometrische Zeitschrift|November 20, 2023
Drug combinations screening using a Bayesian ranking approach based on dose-response modelsLuana Boumendil, Morgane Fontaine, Vincent Lévy, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Cryoglobulinemia after the era of chronic hepatitis C infectionGonçalo Boleto, Pascale Ghillani-Dalbin, Lucile Musset, et al.
Plos One|September 18, 2020
Cardiac sarcoidosis: A long term follow up studyPatrice Cacoub, Catherine Chapelon-Abric, Matthieu Resche-Rigon, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Statistics in Medicine|June 6, 2024
Two-stage randomized clinical trials with a right-censored endpoint: Comparison of frequentist and Bayesian adaptive designsLuana Boumendil, Sylvie Chevret, Vincent Lévy, et al.
Statistics in Medicine|October 19, 2022
Surv-CRM-12: A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progressionAnaïs Andrillon, Sylvie Chevret, Shing M Lee, et al.
Journal of Biopharmaceutical Statistics|November 23, 2020
Dose-finding design and benchmark for a right censored endpointAnaïs Andrillon, Sylvie Chevret, Shing M Lee, et al.
Journal of Biopharmaceutical Statistics|September 15, 2020
A simulation study of approaches for handling disease progression in dose-finding clinical trialsLucie Biard, Bin Cheng, Gulam A Manji, et al.
Clinical Trials (London, England)|April 9, 2024
Dose optimization for cancer treatments with considerations for late-onset toxicitiesLucie Biard, Anaïs Andrillon, Rebecca B Silva, et al.
Plos One|November 21, 2012
Case-only designs in pharmacoepidemiology: a systematic reviewSandra Nordmann, Lucie Biard, Philippe Ravaud, et al.
The Lancet. Infectious Diseases|February 2, 2020
Infectious disease consultation for candidaemiaJerome Lambert, Maja von Cube, Lucie Biard, et al.
Biometrical Journal. Biometrische Zeitschrift|November 20, 2023
Drug combinations screening using a Bayesian ranking approach based on dose-response modelsLuana Boumendil, Morgane Fontaine, Vincent Lévy, et al.
Seminars in Arthritis and Rheumatism|June 11, 2020
Cryoglobulinemia after the era of chronic hepatitis C infectionGonçalo Boleto, Pascale Ghillani-Dalbin, Lucile Musset, et al.
Plos One|September 18, 2020
Cardiac sarcoidosis: A long term follow up studyPatrice Cacoub, Catherine Chapelon-Abric, Matthieu Resche-Rigon, et al.
Pageof 10